Impacts of increasing requirements for research and development (R&D) cost transparency: Literature review March 31, 2023
A literature review of academic and policy papers shows that increasing the transparency of the research and development costs of new medicines is much discussed. We find that advocates expect that transparency would lead to greater trust in the pharmaceutical industry and 'fairer' prices, but others fear it would discourage investment in R&D and impose administrative costs. Evidence to support either set of views is lacking, however.